Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Allison R. Ayala
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
Ophthalmology
Ophthalmology
Related publications
Re: Wells Et Al.: Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results From a Comparative Effectiveness Randomized Clinical Trial (Ophthalmology 2016;123:1351-1359)
Ophthalmology
Ophthalmology
Pss34 - Cost-Effectiveness of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effect of Intravitreal Aflibercept on Recalcitrant Diabetic Macular Edema
International Journal of Retina and Vitreous
Ophthalmology
Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema
JAMA Ophthalmology
Ophthalmology
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema
American Journal of Ophthalmology
Ophthalmology
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Acta Ophthalmologica
Medicine
Ophthalmology
Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment
Ophthalmology
Ophthalmology
Sub-Macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema
Case Medical Research
Macular Laser Grid Alone Versus Combined With Intravitreal Triamcinolone Plus Bevacizumab for Diabetic Macular Edema
Journal of Pharmaceutical and Scientific Innovation
